An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines
|
|||||
An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines Research company Statista posted yesterday a map where coronavirus cases are confirmed, and number of cases as of 30 January. But the outbreak is spreading quickly. . . . → Read More: Infographic – Countries Where Coronavirus Reported An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries. . . . → Read More: Int’l Group Funding Coronavirus Vaccines After 13 and a half years, the intersection of science and business remains a compelling subject, but there are other things I now want to do, and it’s time to bring Science & Enterprise to a close. . . . → Read More: A Good Run A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant. . . . → Read More: Life Science Incubator Gains $100M in Start-Up Funds The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness. . . . → Read More: Organ Chip Devices to Model for Radiation Sickness Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation. . . . → Read More: RSV Nose Drops Vaccine Gets FDA Fast Track Tag A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems. . . . → Read More: Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |